Champions Oncolog (CSBR) Stock Price, Quote & News

Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotec...

Industry: Biotechnology

Sector: Healthcare

Phone: 201 808 8400

Website: www.championsoncology.com

Address:

One University Plaza, Suite 307, Hackensack, United States

BEATOFtheMARKET Oct. 24 at 3:33 PM

10/10 to 10/24 list results $CRWL $CSBR $CSGP $CSM $CSTM 🔥 Cycle Trading Signal plugged into AI 🔥 lists 🔥

0 · Reply

JackieFuqua408 Sep. 21 at 6:37 AM

$CSBR Biotech with niche focus. Thin volume trading. No clear pattern emerging.

0 · Reply

RadioIsotope25 Sep. 18 at 9:47 PM

$RADX Can’t miss webinar for Radiopharmaceutical investors… $ATNM $CLRB $LNTH $CSBR

1 · Reply

GMExAPE Sep. 17 at 9:13 PM

RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $TURB $CSBR $IVVD $CGTX $YXT watching close

2 · Reply

indievestments Sep. 15 at 7:29 PM

$CSBR trading like they got Corellia funding. I guess we'll see tonight.

1 · Reply

S2K_TP Sep. 14 at 8:52 PM

🚨 Major Monday's earnings releases: @everyone $CODA before bell $OPTT after bell $HITI after bell $PLAY after bell $CSBR after bell

0 · Reply

RadioIsotope25 Sep. 12 at 12:33 PM

$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH

0 · Reply

RadioIsotope25 Sep. 11 at 4:53 PM

$RADX Significant Radiopharma deals in 2025 $CSBR $CLRB $NVS

0 · Reply

RadioIsotope25 Sep. 11 at 1:30 AM

$RADX “We are pleased to make a strategic investment in RAD and partner with them to further expand our innovative pipeline,” said Brian Markison, Chief Executive Officer of Lantheus. “Radiopharmaceutical theranostics are changing the way cancer is diagnosed and treated, yet we still have more work to do and are inspired to further advance this field with these two preclinical oncology assets. $LNTH $ATNM $CSBR

3 · Reply

Ned__ryerson Aug. 26 at 9:57 PM

$CSBR this thing is starting to stink again. Oh well, I do wish they would get their shit together.

0 · Reply

Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript

Sep 15, 2025, 4:50 PM EDT - 5 weeks ago

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

Sep 15, 2025, 3:55 PM EDT - 5 weeks ago

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Sep 10, 2025, 4:30 PM EDT - 6 weeks ago

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

Jul 25, 2025, 7:55 AM EDT - 3 months ago

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Jul 23, 2025, 4:00 PM EDT - 3 months ago

Champions Oncology Reports Record Annual Revenue of $57 Million

Jul 21, 2025, 8:30 AM EDT - 3 months ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

Jul 18, 2025, 8:30 AM EDT - 3 months ago

Champions Oncology Announces Appointment of New CEO

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Jun 16, 2025, 2:47 PM EDT - 4 months ago

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

Apr 28, 2025, 9:45 AM EDT - 6 months ago

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Apr 24, 2025, 8:00 AM EDT - 6 months ago

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Mar 11, 2025, 8:07 PM EDT - 8 months ago

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Mar 11, 2025, 3:55 PM EDT - 8 months ago

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Mar 6, 2025, 4:00 PM EST - 8 months ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Feb 18, 2025, 9:00 AM EST - 8 months ago

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Jan 8, 2025, 8:00 AM EST - 10 months ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Dec 27, 2024, 9:00 AM EST - 10 months ago

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Dec 11, 2024, 6:02 PM EST - 11 months ago

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Dec 11, 2024, 4:00 PM EST - 11 months ago

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Dec 5, 2024, 4:30 PM EST - 11 months ago

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Oct 16, 2024, 10:55 AM EDT - 1 year ago

Champions Oncology Announces Agreement with Weill Cornell Medicine

Sep 11, 2024, 8:52 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Sep 11, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Sep 9, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Jul 18, 2024, 6:11 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Jul 18, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Jun 4, 2024, 9:00 AM EDT - 1 year ago

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Mar 12, 2024, 7:21 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Mar 12, 2024, 4:30 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Mar 7, 2024, 9:00 AM EST - 1 year ago

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Mar 6, 2024, 4:35 PM EST - 1 year ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Dec 12, 2023, 5:54 PM EST - 2 years ago

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Dec 12, 2023, 4:00 PM EST - 2 years ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Dec 4, 2023, 4:30 PM EST - 2 years ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Oct 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Addition of Brady Davis as President

Sep 15, 2023, 1:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Sep 13, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Sep 11, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Aug 22, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Aug 1, 2023, 8:45 AM EDT - 2 years ago

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Jul 24, 2023, 6:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Jul 24, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Jul 20, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Apr 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Apr 5, 2023, 9:50 AM EDT - 2 years ago

Champions Oncology Announces $5M Stock Repurchase Program

Mar 17, 2023, 3:52 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript

Mar 15, 2023, 3:50 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.8 Million

BEATOFtheMARKET Oct. 24 at 3:33 PM

10/10 to 10/24 list results $CRWL $CSBR $CSGP $CSM $CSTM 🔥 Cycle Trading Signal plugged into AI 🔥 lists 🔥

0 · Reply

JackieFuqua408 Sep. 21 at 6:37 AM

$CSBR Biotech with niche focus. Thin volume trading. No clear pattern emerging.

0 · Reply

RadioIsotope25 Sep. 18 at 9:47 PM

$RADX Can’t miss webinar for Radiopharmaceutical investors… $ATNM $CLRB $LNTH $CSBR

1 · Reply

GMExAPE Sep. 17 at 9:13 PM

2 · Reply

indievestments Sep. 15 at 7:29 PM

$CSBR trading like they got Corellia funding. I guess we'll see tonight.

1 · Reply

S2K_TP Sep. 14 at 8:52 PM

🚨 Major Monday's earnings releases: @everyone $CODA before bell $OPTT after bell $HITI after bell $PLAY after bell $CSBR after bell

0 · Reply

RadioIsotope25 Sep. 12 at 12:33 PM

$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH

0 · Reply

RadioIsotope25 Sep. 11 at 4:53 PM

$RADX Significant Radiopharma deals in 2025 $CSBR $CLRB $NVS

0 · Reply

RadioIsotope25 Sep. 11 at 1:30 AM

3 · Reply

Ned__ryerson Aug. 26 at 9:57 PM

$CSBR this thing is starting to stink again. Oh well, I do wish they would get their shit together.

0 · Reply

indievestments Aug. 25 at 2:50 PM

$CSBR 20k in the premarket?

0 · Reply

DigitalSigma Aug. 23 at 10:21 AM

$CSBR Champions Oncology Inc is facing preclinical research demand cyclicality

1 · Reply

Ned__ryerson Aug. 19 at 2:55 PM

$CSBR Stock has been showing strength, does anybody know what is up?

1 · Reply

AdiDasRom Aug. 19 at 2:13 PM

$CSBR

0 · Reply

Pacol4 Jul. 26 at 7:59 PM

$CSBR The new CEO's equity compensation seems to be expressing confidence on the data licensing side. 70% is performance based and the lowest target is $15MN in data licensing revenue over any 12 month period. Also from the latest call they appear to be close to funding Corelia ? "And we really hope that over the next couple of months, we're going to be able to fund that company" Can someone confirm whether they have ever said something like this ?

1 · Reply

AdiDasRom Jul. 24 at 6:00 PM

$CSBR Let's be serious, because they had a slightly larger loss than estimated given that they are in various stages of research and do not yet have revenues!? Bullish

0 · Reply

AdiDasRom Jul. 24 at 2:08 PM

$CSBR very bullish

0 · Reply

JeffreyCress Jul. 23 at 8:29 PM

$CSBR great report. Lacking volume/attention.

0 · Reply

JeffreyCress Jul. 23 at 8:16 PM

$CSBR

0 · Reply

indievestments Jul. 18 at 7:45 PM

$CSBR they finally booted Dr. Ronnie. Seems like scaling the data platform is still a few quarters away.

0 · Reply

DARKP00L Jul. 18 at 12:31 PM

$CSBR 08:31 on Jul. 18 2025 Champions Oncology Appoints Rob Brainin As CEO, Effective Aug. 25 #tradeideas

0 · Reply

Market Cap	94.92M
Revenue (ttm)	56.94M
Net Income (ttm)	4.70M
EPS (ttm)	N/A
PE Ratio	33.75
Forward PE	N/A
Profit Margin	8.25%
Debt to Equity Ratio	0.00

Volume	16,300
Avg Vol	25,752
Day's Range	N/A - N/A
Shares Out	13.78M
Stochastic %K	85%
Beta	0.55
Analysts	Strong Sell
Price Target	$12.00